RhoDx
4 employees on LinkedIn · 1 known investors
Find your way into RhoDx
234 people in our graph share verified history with the RhoDx team — schools, employers, funds. One of them is your warm intro.
Richard Heymanunlockedknows Charlie Rodi · together at University of Minnesota (overlapped)
knows the team · via University of Minnesota
×10knows the team · via University of Missouri-Columbia
RhoDx develops cell-free DNA and RNA enrichment technologies for liquid biopsy cancer diagnostics. The company provides ultra-sensitive mutation detection methods to improve the performance and accessibility of liquid biopsy testing.
Founders & leadership
CR
Charlie RodiinFounder and CSOCharlie Rodi held roles including Chief Technology Officer at Trovagene and EVP Genomics at Sequenom, where he worked on cancer detection technologies and circulating nucleic acid analysis. He is now Founder and Chief Scientific Officer of RhoDx, which develops cell-free DNA and RNA enrichment technologies for liquid biopsy cancer diagnostics.
Investors · 1
Competitors · 1
by search overlapCompanies competing with RhoDx for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does RhoDx do?
- RhoDx develops cell-free DNA and RNA enrichment technologies for liquid biopsy cancer diagnostics. The company provides ultra-sensitive mutation detection methods to improve the performance and accessibility of liquid biopsy testing.
- Who founded RhoDx?
- RhoDx was founded by Charlie Rodi.
- Who are RhoDx's investors?
- RhoDx's investors include BioGenerator Ventures.